74° Mostly Cloudy

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
- Local News
- State News
Sports
- Local Sports
- Pro Sports
Lifestyle
- Local Entertainment
Multimedia
Community Choice
Features
Classifieds
- Place Ad
- Legal Notices
Public Notices
Obituaries
E-Edition

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

399.68 -0.97 (-0.24%)

Delayed Quote Updated: 2:58 PM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Natera, Inc. - Common Stock

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Natera to Report its Second Quarter 2023 Results on August 3rd

July 27, 2023

From Natera, Inc.

Via Business Wire

Court Issues Favorable Ruling for Natera in False Advertising Trial Against CareDx; Eliminates all Damages

July 17, 2023

From Natera, Inc.

Via Business Wire

Natera to Participate in Goldman Sachs 44th Annual Global Healthcare Conference

June 06, 2023

From Natera, Inc.

Via Business Wire

Analyst Expectations for Natera's Future ↗

May 30, 2023

Via Benzinga

The Latest Analyst Ratings for Natera ↗

March 03, 2023

Via Benzinga

Natera's Earnings Outlook ↗

February 27, 2023

Via Benzinga

Earnings Scheduled For August 3, 2023 ↗

August 03, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.

Via Benzinga

Natera to Participate in Canaccord Genuity 43rd Annual Growth Conference

August 02, 2023

From Natera, Inc.

Via Business Wire

Natera Earnings Preview ↗

August 02, 2023

Via Benzinga

Natera Files Patent Infringement Suit Against NeoGenomics

July 31, 2023

From Natera, Inc.

Via Business Wire

Natera Announces Completion of Enrollment to the Randomized, Phase III ALTAIR Trial of Signatera™ in Colorectal Cancer

July 28, 2023

From Natera, Inc.

Via Business Wire

What 7 Analyst Ratings Have To Say About Natera ↗

July 21, 2023

Via Benzinga

Natera Announces Data from the ProActive Study that Supports Prospera™ Kidney as an Early Indicator of Transplant Rejection

June 04, 2023

From Natera, Inc.

Via Business Wire

New Natera Data to be Presented at the 2023 ASCO Annual Meeting in 13 Studies Across Multiple Cancer Types

May 30, 2023

From Natera, Inc.

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

May 26, 2023

Via Benzinga

Jury Rules in Favor of Natera, Finding all Asserted Patents Valid and Infringed by ArcherDX/Invitae; Awards $19.35 Million in Past Damages for Royalties and Lost Profits

May 15, 2023

From Natera, Inc.

Via Business Wire

Natera Reports First Quarter 2023 Financial Results

May 09, 2023

From Natera, Inc.

Via Business Wire

Natera Announces New Publication from I-SPY2 Trial Reinforcing Clinical Utility of Signatera™ for Breast Cancer Patients in the Neoadjuvant Setting

May 08, 2023

From Natera, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2023 ↗

May 05, 2023

Via Benzinga

Natera Announces First Quarter 2023 Earnings Conference Call

May 02, 2023

From Natera, Inc.

Via Business Wire

Natera Announces New Signatera™ MRD Data at 2023 AACR Annual Meeting

April 14, 2023

From Natera, Inc.

Via Business Wire

New Publication Demonstrates Utility of Natera’s Signatera™ Test in Melanoma

March 22, 2023

From Natera, Inc.

Via Business Wire

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗

March 15, 2023

To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.

Via InvestorPlace

Catalent Stock Showing Improved Relative Strength Rating ↗

March 10, 2023

On Friday, Catalent stock earned a positive adjustment to its Relative Strength (RS) Rating, from 63 to 74.

Via Investor's Business Daily

Natera Announces Commercial Payor Coverage for Signatera™

March 02, 2023

From Natera, Inc.

Via Business Wire

Natera Reports Fourth Quarter and Full Year 2022 Financial Results

February 28, 2023

From Natera, Inc.

Via Business Wire

Natera to Participate in Upcoming Investor Conferences

February 24, 2023

From Natera, Inc.

Via Business Wire

Natera Appoints Ruth E. Williams-Brinkley to its Board of Directors

February 23, 2023

From Natera, Inc.

Via Business Wire

Earnings Scheduled For February 28, 2023 ↗

February 28, 2023

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.

Via Benzinga

Natera Announces Fourth Quarter and Fiscal 2022 Earnings Conference Call

February 21, 2023

From Natera, Inc.

Via Business Wire

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Multimedia
Local Events
Classifieds
Obituaries
Weather
Online Features

Services

About Us
Contact Us
Promote Your Event
Subscriber Services
Online Forms
Rack Locations

woonsocketcall.com
Address: 154 Main Street
Woonsocket, RI 02895
Phone: 401-762-3000
Email: notices@woonsocketcall.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Natera, Inc. - Common Stock (NQ:NTRA)

All News about Natera, Inc. - Common Stock

Sections

Services